Search research articles
Contact Us
Filters
Showing results (1-10 of 38) with videos related to
Page
of 4
Sort By:
Journal of Neurovirology
|
November 7, 2003
In vitro modulation of the multiple sclerosis (MS)-associated retrovirus by cytokines: implications for MS pathogenesis
Caterina Serra, Giuseppe Mameli, Giannina Arru, et al.
Viruses
|
November 27, 2021
TDP-43 and HERV-K Envelope-Specific Immunogenic Epitopes Are Recognized in ALS Patients
Elena Rita Simula, Giannina Arru, Ignazio Roberto Zarbo, et al.
Journal of Neuroimmunology
|
April 7, 2016
Is there a role for Mycobacterium avium subspecies paratuberculosis in Parkinson's disease?
Giannina Arru, Elisa Caggiu, Kai Paulus, et al.
Eneurologicalsci
|
September 27, 2018
Differential expression of miRNA 155 and miRNA 146a in Parkinson's disease patients
Elisa Caggiu, Kai Paulus, Giuseppe Mameli, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques
|
November 1, 2008
NRAMP1 polymorphism and viral factors in Sardinian multiple sclerosis patients
Maria Gazouli, Leonardo Sechi, Daniela Paccagnini, et al.
AIDS Research and Human Retroviruses
|
June 25, 2002
Characterization of an HIV type 1 strain with preferential replication in adherent cells
Caterina Serra, Giuseppe Mameli, Adriana Biolchini, et al.
Journal of Neuroimmunology
|
February 10, 2016
Humoral cross reactivity between α-synuclein and herpes simplex-1 epitope in Parkinson's disease, a triggering role in the disease?
Elisa Caggiu, Kai Paulus, Giannina Arru, et al.
Microorganisms
|
October 11, 2019
Association between Lipoprotein Levels and Humoral Reactivity to <i>Mycobacterium avium</i> subsp. <i>paratuberculosis</i> in Multiple Sclerosis, Type 1 Diabetes Mellitus and Rheumatoid Arthritis
Marco Bo, Giannina Arru, Magdalena Niegowska, et al.
Microorganisms
|
April 5, 2020
IL-2 and Mycobacterial Lipoarabinomannan as Targets of Immune Responses in Multiple Sclerosis Patients
Marco Bo, Magdalena Niegowska, Jessica Frau, et al.
Journal of the Neurological Sciences
|
July 21, 2015
Natalizumab modulates the humoral response against HERV-Wenv73-88 in a follow-up study of Multiple Sclerosis patients
Giannina Arru, Elisa Caggiu, Stefania Leoni, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 38) with videos related to
Sort By:
Page
of 4
Journal of Neurovirology
|
November 7, 2003
In vitro modulation of the multiple sclerosis (MS)-associated retrovirus by cytokines: implications for MS pathogenesis
Caterina Serra, Giuseppe Mameli, Giannina Arru, et al.
Viruses
|
November 27, 2021
TDP-43 and HERV-K Envelope-Specific Immunogenic Epitopes Are Recognized in ALS Patients
Elena Rita Simula, Giannina Arru, Ignazio Roberto Zarbo, et al.
Journal of Neuroimmunology
|
April 7, 2016
Is there a role for Mycobacterium avium subspecies paratuberculosis in Parkinson's disease?
Giannina Arru, Elisa Caggiu, Kai Paulus, et al.
Eneurologicalsci
|
September 27, 2018
Differential expression of miRNA 155 and miRNA 146a in Parkinson's disease patients
Elisa Caggiu, Kai Paulus, Giuseppe Mameli, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques
|
November 1, 2008
NRAMP1 polymorphism and viral factors in Sardinian multiple sclerosis patients
Maria Gazouli, Leonardo Sechi, Daniela Paccagnini, et al.
AIDS Research and Human Retroviruses
|
June 25, 2002
Characterization of an HIV type 1 strain with preferential replication in adherent cells
Caterina Serra, Giuseppe Mameli, Adriana Biolchini, et al.
Journal of Neuroimmunology
|
February 10, 2016
Humoral cross reactivity between α-synuclein and herpes simplex-1 epitope in Parkinson's disease, a triggering role in the disease?
Elisa Caggiu, Kai Paulus, Giannina Arru, et al.
Microorganisms
|
October 11, 2019
Association between Lipoprotein Levels and Humoral Reactivity to <i>Mycobacterium avium</i> subsp. <i>paratuberculosis</i> in Multiple Sclerosis, Type 1 Diabetes Mellitus and Rheumatoid Arthritis
Marco Bo, Giannina Arru, Magdalena Niegowska, et al.
Microorganisms
|
April 5, 2020
IL-2 and Mycobacterial Lipoarabinomannan as Targets of Immune Responses in Multiple Sclerosis Patients
Marco Bo, Magdalena Niegowska, Jessica Frau, et al.
Journal of the Neurological Sciences
|
July 21, 2015
Natalizumab modulates the humoral response against HERV-Wenv73-88 in a follow-up study of Multiple Sclerosis patients
Giannina Arru, Elisa Caggiu, Stefania Leoni, et al.
Page
of 4